Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-12-001335
Filing Date
2012-04-20
Accepted
2012-04-20 10:56:06
Documents
2
Period of Report
2012-04-20

Document Format Files

Seq Description Document Type Size
1 FORM 6-K FILING DOCUMENT document.htm 6-K 4383
2 PRESS RELEASE newsrelease.htm EX-99 9584
  Complete submission text file 0001171843-12-001335.txt   15030
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
TEKMIRA PHARMACEUTICALS Corp (Filer) CIK: 0001447028 (see all company filings)

EIN.: 980597776 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-34949 | Film No.: 12769923
SIC: 2834 Pharmaceutical Preparations